PegIntron: Indications, Dosage, Precautions, Adverse Effects
Россия
  • Россия
  • Украина

Manufacture: Merck and Co., Inc.
Country: Canada
Condition: Chronic Myelogenous Leukemia, Hepatitis B, Hepatitis C, Melanoma, Melanoma, Metastatic, Renal Cell Carcinoma, Thrombocythemia
Class: Antineoplastic interferons, Antiviral interferons
Form: Liquid solution, Subcutaneous (SC)
Ingredients: peginterferon alfa-2b, dibasic sodium phosphate anhydrous, monobasic sodium phosphate dihydrate, sucrose, polysorbate 80. Sterile water for injection is supplied as a diluent